Senior insider sale
Chief Medical Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$1.08M
208.68K shares
What this filing means
JAMIL KHURRAM plans to sell 208.68K shares of GALECTIN THERAPEUTICS INC valued at approximately $1.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2026ACC: 0001972481-26-000012
Officer· Chief Medical Officer
Since Aug 2024
208.68K
Shares to sell
$1.08M
Approx. market value
60K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
1/1/2026
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2026 | Restricted Stock Units Equity Compensation | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
8.13K
Market value
$33.1K
12/31/2025
—Completed
Units to sell
19.44K
Market value
$136.9K
12/17/2025
—Completed
Units to sell
121.12K
Market value
$662.2K
11/13/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
60K
Market value
$252.0K
1/2/2026
Total
Units
208.68K
Value
$1.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/31/2025 | 8.13K | $33.1K | — | Completed |
12/17/2025 | 19.44K | $136.9K | — | Completed |
11/13/2025 | 121.12K | $662.2K | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 60K | $252.0K | Nasdaq | Planned |
| Total | 208.68K | $1.08M | ||